DTwP-HebB-Hib vaccine - Shantha Biotechnics

Drug Profile

DTwP-HebB-Hib vaccine - Shantha Biotechnics

Alternative Names: Diphtheria, Tetanus, Pertussis, Haemophilus influenza B, and Hepatitis B vaccine - Shantha Biotechnics; Hib-DTP-hepatitis-B vaccine - Shantha Biotechnics; Pentavalent vaccine - Shantha Biotechnics; Shan 5; Shan5

Latest Information Update: 22 Nov 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Shantha Biotechnics
  • Class Haemophilus vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 05 May 2014 Shan5™ receives WHO prequalification status for the prevention of Diptheria, Tetanus, Pertussis, Haemophilus infections and Hepatitis B
  • 31 Mar 2014 Registered for Diphtheria, Tetanus, Pertussis, Haemophilus infections and Hepatitis B (prevention) in India (IM)
  • 03 Sep 2012 Phase-III clinical trials in Diphtheria, Tetanus, Pertussis, Haemophilus infections and Hepatitis B (prevention) in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top